Literature DB >> 15678460

Early experience in the application of distal protection devices in treatment of peripheral vascular disease of the lower extremities.

Michael H Wholey1, Boulis Toursarkissian, Darren Postoak, Bala Natarajan, Donald Joiner.   

Abstract

The objectives of this study were to reduce the risk of showering distal vessels with thromboemboli created during percutaneous interventions of the arteries in the lower extremities. Distal protection devices have been used in coronary and carotid interventions. Hence, using similar techniques, these filters and occlusion balloons were advanced past the targeted lesions and distally into femoral and popliteal arteries. Once opened, these devices allowed standard angioplasty and stent placement and captured the dislodged thromboemboli. Five cases were performed with the distal protection devices. One case used the distal occlusion balloon and four with the filter system. All five passed the lesion and were deployed. All five devices were retrieved without incident and were retrieved with substantial debris. There were no adverse events. The use of distal protection to treat high-risk or unstable lesions in the lower extremities shows great promise. Further case will be needed to evaluate the device for feasibility and safety. 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2005        PMID: 15678460     DOI: 10.1002/ccd.20254

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  2 in total

1.  Plaque Excision in Management of Lower Extremity Peripheral Arterial Disease with the SilverHawk Atherectomy Catheter.

Authors:  Martin G Radvany; R Stefan Kiesz
Journal:  Semin Intervent Radiol       Date:  2008-03       Impact factor: 1.513

2.  The results of a new distal protection method in intervention for chronic total occlusion of the superficial femoral artery.

Authors:  Tomoko Kobayashi; Atsushi Funatsu; Emiko Ejima; Hiromi Muranishi; Makoto Utsunomiya; Kensaku Shibata; Masahiro Mizobuchi; Yoshihisa Enjoji; Shigeru Nakamura
Journal:  Cardiol Res Pract       Date:  2009-09-01       Impact factor: 1.866

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.